4.2 Editorial Material

An improved reprogrammable mouse model harbouring the reverse tetracycline-controlled transcriptional transactivator 3

Journal

STEM CELL RESEARCH
Volume 17, Issue 1, Pages 49-53

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.scr.2016.05.008

Keywords

-

Funding

  1. Silvia and Charles Senior Medical Viertel Fellowship
  2. National Stem Cell Foundation of Australia
  3. National Health and Medical Research Council of Australia (NHMRC) [APP1085302]
  4. Australia Research Council's special initiative Stem Cells Australia
  5. Australian Postgraduate Award (APA) scheme
  6. NHMRC [APP1092280]

Ask authors/readers for more resources

Reprogrammable mouse models engineered to conditionally express Oct-4, Klf-4, Sox-2 and c-Myc (OKSM) have been instrumental in dissecting molecular events underpinning the generation of induced pluripotent stem cells. However, until now these models have been reported in the context of the m2 reverse tetracycline-controlled transactivator, which results in low reprogramming efficiency and consequently limits the number of reprogramming intermediates that can be isolated for downstream profiling. Here, we describe an improved OKSM mouse model in the context of the reverse tetracycline-controlled transactivator 3 with enhanced reprogramming efficiency (>9-fold) and increased numbers of reprogramming intermediate cells albeit with similar kinetics, which we believe will facilitate mechanistic studies of the reprogramming process. (C) 2015 The Authors. Published by Elsevier B.V.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available